MedPath
HSA Approval

CLOPISWIFT FILM-COATED TABLET 75MG

SIN17130P

CLOPISWIFT FILM-COATED TABLET 75MG

CLOPISWIFT FILM-COATED TABLET 75MG

October 30, 2024

SEA PHARMA CONSULTANCY PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSEA PHARMA CONSULTANCY PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B01AC04

Manufacturer Information

SEA PHARMA CONSULTANCY PTE. LTD.

IND-SWIFT LIMITED

Active Ingredients

Clopidogrel hydrogen sulphate equivalent to Clopidogrel

75 mg

Clopidogrel

Documents

Package Inserts

Clopiswift Film-Coated Tablet PI.pdf

Approved: October 30, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLOPISWIFT FILM-COATED TABLET 75MG - HSA Approval | MedPath